in

Crane Venture Partners Raises €419M to Expand Global Platform

The big picture: London’s Crane Venture Partners has raised €419 million across four investment vehicles, alongside plans to create an inception-to-Seed venture platform in partnership with MassMutual Ventures (MMV).

Why it matters:

  • Global Reach: Crane’s strategy addresses the uneven distribution of opportunity by backing outlier founders globally, from inception to Seed stage.
  • Market Trend: The fundraise contributes to a period of sustained capital formation among UK and European venture investors, with comparable announcements totaling approximately €1.36 billion in 2026.
  • Strategic Alliance: A deepened collaboration with MassMutual Ventures, an anchor investor since 2018, underpins Crane’s United States expansion and global platform administration.

How it works:

  • Multi-Vehicle Strategy: The €419 million is distributed across Crane III (€146M), Crane APAC I (€129M), Crane US I (€86M), and Crane Opportunity Fund (€56M).
  • Inception-to-Seed Focus: Crane supports founders from the earliest stages, maintaining a partner presence within portfolio companies.
  • Connected Platform: The firm provides founders with access to capital, customers, talent, and expertise across its global network, enabling companies to build internationally from day one.

The catch: The UK and European venture capital market remains highly competitive, with numerous large funds recently announced. Crane’s global platform must demonstrate a unique value proposition and effective execution to differentiate itself from established local players and other globally-minded firms.

Key Facts

  • Company: Crane Venture Partners
  • Amount: €419M
  • Investor: MassMutual Ventures (lead)
  • Founders: Krishna Visvanathan, Scott Sage
  • Announced: 2026-09-05
  • Sector: Venture Capital
  • Headquarters: London, UK
Joscha Specks, CEO and co-founder of Depotcharge.

Depotcharge Raises €2.7M to Expand EV Charging

Dr. Fozia Saleem, CEO of Magnitude Biosciences.

Magnitude Biosciences Raises €1.5M to Scale Drug Discovery